Contract Services Pre-Clinical Outsourcing
Ajinomoto Bio-Pharma Services Receives FDA Approval for High Potency Fill Line
"Receiving FDA approval on our HPAPI fill line is an exciting milestone for our company, and couldn't have happened without the hard work, hours of prepara...
April 20, 2023 | News
Crystal Formulation Services Receives China Drug Manufacturing License for Milestone Formulation Capability
Crystal Formulation Services, a subsidiary of Crystal Pharmatech, has achieved an exciting new milestone in its formulation capabilities. The company was r...
April 20, 2023 | News
Catalent builds $20M expansion for German clinical supply facility
Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it has begun construction of ...
April 06, 2023 | News
Bridgewest Group launches NovaCina, new sterile injectable CDMO
The newly acquired facility and team is in Bentley, a suburb of Perth in Western Australia. It will operate as a Contract Development and Ma...
April 05, 2023 | News
Veranova Proposes Closure of Annan Facility
Over the last several months, Veranova conducted a review of its manufacturing capacity relative to customer needs and market trends across its product por...
March 27, 2023 | News
TransCure bioServices delivers CDX mouse models to advance AML preclinical studies
TransCure bioServices has developed cell line-derived xenograft (CDX) mouse models that will change how researchers tackle the preclinical studies of cance...
March 07, 2023 | News
Aqilion announces pre-clinical licensing and strategic research collaboration agreement with Merck
In addition, Aqilion is eligible to receive potential development and commercialization milestones up to over EUR 950 million and tiered royaltie...
February 17, 2023 | News
AcuraBio expands cGMP plasmid DNA CDMO services with Cytiva
AcuraBio selects Cytiva's latest two-step purification protocol to offer a productive plasmid DNA service to its customers globally to alleviate supply c...
February 10, 2023 | News
Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™
Two distinctive platforms will streamline the antibody development process. With an advanced design and high binding affinity, S-DUAL™ ensures opt...
September 30, 2022 | News
Merck Becomes One of the First CDMOs to Provide Full Viral Vector Offering with Launch of VirusExpress® 293 Adeno-Associated Virus Production Platform
Reduces process development time by an estimated 40 percent Enables biopharmaceutical companies to increase the speed to clinical manufacturing ...
August 10, 2022 | News
Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15
-Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced the initiation of a Phase 3 clinical study, Vacc...
August 09, 2022 | News
LG Chem Enters Final Stage of Clinical Development for New Gout Drug
In global Phase 3 clinical trial, Tigulixostat will be evaluated in 350 adult gout patients with hyperuricemia for safety and efficacy at Month 6 of treatm...
August 04, 2022 | News
Biosynth Carbosynth Expands Peptide Offering with Acquisition of Pepscan
Biosynth Carbosynth (“Biosynth”), a supplier of critical products and services to the life sciences industry, announces today the acquisition o...
July 01, 2022 | News
WuXi Biologics Launches First Commercial Drug Product Facility for Pre-Filled Syringes
WuXi Biologics offers global partners high-efficiency and high-quality manufacturing services for clinical trial and commercial supply by increasing pre-...
June 06, 2022 | News
Most Read
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
